Send to

Choose Destination
CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89.

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.

Author information

Cancer Control Science Department, American Cancer Society, Atlanta, GA, USA.

Erratum in

  • CA Cancer J Clin. 2007 May-Jun;57(3):185.


New evidence on breast Magnetic Resonance Imaging (MRI) screening has become available since the American Cancer Society (ACS) last issued guidelines for the early detection of breast cancer in 2003. A guideline panel has reviewed this evidence and developed new recommendations for women at different defined levels of risk. Screening MRI is recommended for women with an approximately 20-25% or greater lifetime risk of breast cancer, including women with a strong family history of breast or ovarian cancer and women who were treated for Hodgkin disease. There are several risk subgroups for which the available data are insufficient to recommend for or against screening, including women with a personal history of breast cancer, carcinoma in situ, atypical hyperplasia, and extremely dense breasts on mammography. Diagnostic uses of MRI were not considered to be within the scope of this review.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center